Kallikrein Inhibitors

Plasma Kallikrein Inhibitor

Angioedemas, Hereditary

<section class="Section" data-sectioncode="34089-3"><a name="S11"></a><a name="section-10"></a><p></p><h1>11 DESCRIPTION</h1><p class="First">KALBITOR (ecallantide) is a human plasma kallikrein inhibitor for injection for subcutaneous use.  Ecallantide is a 60-amino-acid protein produced in <span class="Italics">Pichia pastoris</span> yeast cells by recombinant DNA technology.</p><p>KALBITOR is a clear and colorless, sterile, and nonpyrogenic solution.  Each vial contains 10 mg ecallantide as the active ingredient, and the following inactive ingredients: 0.76 mg disodium hydrogen orthophosphate (dihydrate), 0.2 mg monopotassium phosphate, 0.2 mg potassium chloride, and 8 mg sodium chloride in water for injection, USP.  KALBITOR is preservative free, with a pH of approximately 7.0.  A 30 mg dose is supplied as 3 vials each containing 1 mL of 10 mg/mL KALBITOR.  Vials are intended for single use.</p></section>

Kalbitor

ecallantide

1 ML ecallantide 10 MG/ML Injection

1 ML ecallantide 10 MG/ML Injection [Kalbitor]

Psoriasis (PsO)

Psoriatic Arthritis (PsA)

Ankylosing Spondylitis (AS)

Nonradiographic Axial Spondyloarthritis

Taltz

Juvenile Idiopathic Arthritis

Hidradenitis Suppurativa (HS)

Cosentyx

Siliq

Tremfya

Crohn's Disease (CD)

Ulcerative Colitis (UC)

Stelara

Skyrizi

Ilumya

Migraine

Cluster Headache

Migraine Prevention

Emgality

Qulipta

Acute Migraine

Ubrelvy

Nurtec ODT

Vyepti

Aimovig

Ajovy

Breast Cancer: HR+ (HER2-)

Verzenio

Ibrance

Kisqali

Atopic Dermatitis (Eczema)

Cibinqo

Eucrisa

Asthma (injectable)

Asthma OCS Dependent

Nasal Polyposis

Eosinophilic Esophagitis (EoE)

Prurigo Nodularis

Dupixent

Opzelura

Adbry

NSCLC ALK+ OR ROS1+ Disease

Lorbrena

Alecensa

Alunbrig

NSCLC cMET Mutation

Xalkori

Rheumatoid Arthritis (RA)

Xeljanz

Uveitis

Graft Versus Host Disease (GVHD)

Orencia

COVID-19 Treatment

Alopecia Areata

Olumiant

Multiple Sclerosis (MS)

Secondary Progressive Multiple Sclerosis

Zeposia

Rinvoq

Entyvio

Kalbitor is employed to manage hereditary angioedema attacks, an immune system disorder. It is suitable for adults and children aged 12 years and older.

It's important to note that Kalbitor does not provide a cure for hereditary angioedema.


Report Adverse Event

Prescribing Information

Medication Guide

Prescribing Information - Spanish

Submit MSL Request

Pharmacy List 

Coverage Authorization Request

Coverage Authorization Appeals

Enroll in Patient Savings Program 

Kalbitor Start Form 

About Kalbitor 

Side Effects 

Doctor Discussion Guide 

OnePath Support Services 

FAQs: Hereditary Angioedema (HAE)

Kalbitor Start Guide

Instructions For Use: Hereditary Angioedema (HAE) 